Skip to main content
Aker BioMarine logo

Aker BioMarine — Investor Relations & Filings

Ticker · AKBM ISIN · NO0010886625 LEI · 549300V34T6VWDSYWE64 OL Agriculture, forestry and fishing
Filings indexed 508 across all filing types
Latest filing 2025-06-20 Capital/Financing Update
Country NO Norway
Listing OL AKBM

About Aker BioMarine

https://www.akerbiomarine.com/

Aker BioMarine is a biotechnology innovator that sustainably harvests Antarctic krill to develop and supply krill-derived ingredients. The company's core business focuses on producing ingredients for the human health and nutrition markets, including nutraceuticals and dietary supplements. It also serves the aquaculture and animal feed sectors with specialized products. Aker BioMarine leverages its vertically integrated supply chain and scientific research to create a portfolio of products that extends to agricultural biostimulants and pharmaceutical applications. The company is committed to sustainable operations and the scientific validation of its marine-based ingredients.

Recent filings

Filing Released Lang Actions
Euronext Oslo Børs – Aker BioMarine ASA - Mottatt søknad om notering av obligasjonslån
Capital/Financing Update Classification · 99% confidence The document text is very short (388 characters) and announces that Euronext Oslo Børs has received an application for the listing of a bond loan (obligasjonslån) identified by ISIN NO0013326025. This is a regulatory announcement concerning a financial instrument listing, but it is not a comprehensive report like an Annual Report (10-K) or an Interim Report (IR). It does not fit clearly into categories like Dividends (DIV), Director's Dealing (DIRS), or Capital Changes (CAP). Since it is a specific regulatory announcement about a listing application that doesn't fit the highly specific financial report categories, the most appropriate general regulatory filing category is Regulatory Filings (RNS), as it serves as a catch-all for official, non-standard announcements.
2025-06-20 Norwegian
Euronext Oslo Børs – Aker BioMarine ASA - Received application for listing of bonds
Regulatory Filings Classification · 99% confidence The document text is very short (446 characters) and announces that Euronext Oslo Børs has received an application for listing of bonds (ISIN NO0013326025) for Aker BioMarine ASA. This is a specific regulatory announcement concerning a financial instrument listing, which does not fit neatly into the primary financial report categories (10-K, IR, ER). It is not a management change (MANG), director dealing (DIRS), dividend notice (DIV), or a general shareholder vote item. Since it is a specific regulatory notice that doesn't match the other specialized categories, the most appropriate classification is the general regulatory fallback category, Regulatory Filings (RNS).
2025-06-20 Norwegian
Aker BioMarine ASA – Base prospectus approved for listing of bonds - Attachment: Aker BioMarine ASA Base Prospectus.pdf
Audit Report / Information Classification · 98% confidence The document is titled "Base Prospectus" and dated June 16, 2025. It explicitly discusses the potential issuance of bonds, includes extensive sections on 'Risk Factors,' references regulatory frameworks like the PRIIPs Regulation and MiFID II product governance, and details the structure for issuing financial instruments. A Base Prospectus is a core document used in capital markets for debt issuance (like bonds) to inform potential investors, which aligns closely with financing activities. While it contains financial information, its primary purpose is to facilitate a capital raising event. This fits best under 'Capital/Financing Update' (CAP), as it is the document enabling the offering of bonds, rather than a standard periodic report (10-K, IR) or a simple announcement (RPA/ER). FY 2025
2025-06-16 English
Aker BioMarine ASA – Base prospectus approved for listing of bonds
Regulatory Filings Classification · 95% confidence The document announces that the Financial Supervisory Authority of Norway has approved a 'Base prospectus' for the listing of the company's bond issue on the Oslo Stock Exchange. It explicitly states that the prospectus and Final Terms are available on the company website. This is a regulatory announcement concerning a financing instrument (bond listing) and the publication of a key document (prospectus). Since the text is short and primarily serves to announce the availability of the prospectus rather than being the prospectus itself, it fits the description of a Report Publication Announcement (RPA) or a general Regulatory Filing (RNS). Given that 'Capital/Financing Update' (CAP) covers fundraising and financing activities, and this announcement is directly tied to the listing of a bond issue, CAP is a strong candidate. However, the core action described is the approval and publication of the prospectus document. Since the document is short and announces the availability of a formal document (prospectus), RPA is highly relevant. Comparing CAP (updates on fundraising) and RPA (announcement of report publication), the document is fundamentally an announcement about the approval and availability of the prospectus related to a financing event. Given the specific nature of the financing (bond listing) and the document type (prospectus), CAP is slightly more specific than RPA, but RPA aligns perfectly with the 'MENU VS MEAL' rule for short announcements pointing to a formal document. Since a prospectus is a key document in a financing event, I will lean towards CAP as the primary context, but acknowledge the RPA nature. Let's re-evaluate the definitions. CAP is for 'Updates on company fundraising, financing activities, or capital structure changes.' This is exactly what an approved bond prospectus listing is. Therefore, CAP is the most appropriate classification.
2025-06-16 English
Mandatory notification of trade
Director's Dealing Classification · 99% confidence The document text is titled 'K R T - 1 5 0 0 Skjema for melding om transaksjoner utført av personer med ledelsesansvar («primærinnsidere») og deres nærstående' (Form for reporting transactions carried out by persons discharging managerial responsibilities ('primary insiders') and their related persons). It details a transaction (Kjøp/Buy) involving shares (Aksje) by an individual identified as a 'Primærinnsider' (Primary Insider) and lists their role as 'Board member'. This structure and content are characteristic of mandatory insider trading disclosures, specifically reporting personal share transactions by directors and executives. This aligns directly with the definition for Director's Dealing (DIRS).
2025-05-02 Norwegian
Mandatory notification of trade
Director's Dealing Classification · 100% confidence The document is titled 'Mandatory notification of trade' and explicitly states that a Board director, Kimberly Mathisen, purchased shares. This directly relates to insider trading or director transactions. The definition for Director's Dealing (DIRS) covers 'Report of personal share transactions by company directors and executives (insider trades)'. Although it mentions an attached form pursuant to MAR, the core content is the director's trade notification, making DIRS the most appropriate classification over a general RPA or RNS.
2025-05-02 English

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.